- Home
- CGO vs MIST Comparison
CGO vs MIST Comparison
Compare CGO & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CGO | MIST |
|---|---|---|
| Founded | 2004 | 2003 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 129.6M | 131.3M |
| IPO Year | 2004 | 2019 |
Fundamental Metrics
Financial Performance| Metric | CGO | MIST |
|---|---|---|
| Price | $13.20 | $1.15 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 30.8K | ★ 1.7M |
| Earning Date | 01-01-0001 | 05-13-2026 |
| Dividend Yield | ★ 9.25% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $2,915.14 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.71 | $1.00 |
| 52 Week High | $14.20 | $3.06 |
Technical Indicators
Market Signals| Indicator | CGO | MIST |
|---|---|---|
| Relative Strength Index (RSI) | 49.95 | 43.93 |
| Support Level | $12.97 | $1.01 |
| Resistance Level | $13.71 | $1.42 |
| Average True Range (ATR) | 0.28 | 0.07 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 32.85 | 22.22 |
Price Performance
Historical ComparisonAbout CGO Calamos Global Total Return Fund
Calamos Global Total Return Fund is a closed-end management investment company. The fund's investment objective is to provide total return through a combination of capital appreciation and current income. The fund invests in equities, convertible securities, and high-yield corporate bonds.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.